Revisión sistemática y metaanálisis sobre eficacia de las drogas vasoactivas en el shock hemorrágico en animales
Systematic review and meta-analysis on the efficacy of vasoactive drugs in hemorrhagic shock in animals
Rev. chil. anest; 51 (4), 2022
Publication year: 2022
The objective of this review was to evalúate the efficacy of the use of vasoactive drugs in the initial resuscitation of hemorrhagic shock in animals.
The search was developed using the databases:
Cochrane Central Register of Controlled Trials, PUBMED, MEDLINE, EMBASE, the database was also included: Clinical Trial.gov; no date restriction of publication or language. We included randomized controlled clinical trials in animals that compared the use of vasoactive drugs with any other resuscitation strategy for hemorrhagic shock. The analysis was developed using of review manager version 5.4, with the random effects model and the Mantel Haenszel method for dichotomous data. Statistical heterogeneity was evaluated with the statisgraph I. The strength of evidence was assessed for each outcome according to the statements of the working group for the classification of the quality of the evidence (GRADE). 18 trials (n = 533 participant) were included in this meta-analysis. Compared with control, vasopressors were associated with lower relative risk of mortality during initial resuscitation from hae- morrhagic shock, with an overall risk estimate of 0.53 (0.39, 0.71) 95% confidence interval. There is evidence of the efficacy of vasopressors in resuscitation hemorrhagic shock in animals, this is of moderate to low quality; Therefore, it is necessary to develop and implement randomized clinical trials that allow an evaluation of the efficacy and safety of these drugs in humans for their use systematically in patients with hemorrhagic shock.
El objetivo de esta revisión fue evaluar la eficacia del uso de drogas vasoactivas en la resucitación inicial del hemorrágico en animales.